Evaluation of CYP3A5, VEGF-a, and VEGFR2 polymorphisms as markers of sunitinib toxicity.
Cristina Rodriguez de Antona
No relevant relationships to disclose
Enrique Grande Pulido
Consultant or Advisory Role - Pfizer
Lj Leandro-Garcia
No relevant relationships to disclose
Jorge Barriuso
No relevant relationships to disclose
Jaume Capdevila
No relevant relationships to disclose
Paula Jimenez
No relevant relationships to disclose
Beatriz Castelo
No relevant relationships to disclose
Daniel E. Castellano
No relevant relationships to disclose
Federico Longo
No relevant relationships to disclose
Jesus Garcia-Donas
No relevant relationships to disclose